Vildan Avkan-Oğuz
-
- Antibiotic Use and Resistance 9
- Molecular Medicine top 10%
- Infectious Diseases top 10%
- Antifungal resistance and susceptibility 10
- Tuberculosis Research and Epidemiology 6
- COVID-19 Clinical Research Studies 5
- Transplantation top 10%
-
- Mycobacterium research and diagnosis 6
- Cytomegalovirus and herpesvirus research 6
- Urinary Tract Infections Management 5
-
- Appendicitis Diagnosis and Management 5
- Co-authors
- Nur YaparGüven AslanTarkan ÜnekAyşe YüceSema Alp ÇavuşMücahit ÖzbilginMert AkanSevda Özkardeşler
- Journals
- SHILAP Revista de lepidopterología (6 papers)Journal of Antimicrobial Chemotherapy (1 paper)Vaccine (1 paper)
- Partner nations
- TürkiyeUnited StatesKazakhstan
In The Last Decade
Vildan Avkan-Oğuz
54 papers receiving 517 citations
Peers
Comparison fields: 5 of 86
- Applied Microbiology and Biotechnology 51
- Molecular Medicine 58
- Infectious Diseases 205
- Transplantation 28
- Epidemiology 222
Countries citing papers authored by Vildan Avkan-Oğuz
This map shows the geographic impact of Vildan Avkan-Oğuz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vildan Avkan-Oğuz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vildan Avkan-Oğuz more than expected).
Fields of papers citing papers by Vildan Avkan-Oğuz
This network shows the impact of papers produced by Vildan Avkan-Oğuz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vildan Avkan-Oğuz. The network helps show where Vildan Avkan-Oğuz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Vildan Avkan-Oğuz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2022 | 35 | |
| 4 | 2022 | 13 | |
| 5 | 2021 | 6 | |
| 6 | 2021 | 2 | |
| 7 | 2020 | 2 | |
| 8 | Yaşlılarda ve Kronik Hastalığı Olanlarda COVID-19 Enfeksiyonu | 2020 | 0 |
| 9 | 2019 | 0 | |
| 10 | 2018 | 1 | |
| 11 | Heteroresistant vancomycin intermediate S. aureus (h-VISA) isolated from a patient with orthopedic implant infection treated with glycopeptides: A case report | 2017 | 1 |
| 12 | 2016 | 20 | |
| 13 | Candiduria Among Intensive Care Unit Patients Undergoing Urinary Catheterization: Risk Factors, Effect On Candidemia and Mortality | 2015 | 1 |
| 14 | Various Specialist Approaches for the Management of Candiduria: A Questionnaire Study | 2015 | 1 |
| 15 | 2015 | 20 | |
| 16 | 2011 | 2 | |
| 17 | 2010 | 52 | |
| 18 | 2008 | 23 | |
| 19 | 2005 | 26 | |
| 20 | 2004 | 7 |
About Vildan Avkan-Oğuz
Vildan Avkan-Oğuz is a scholar working on Applied Microbiology and Biotechnology, Infectious Diseases and Epidemiology, having authored 65 papers that have together received 534 indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (10 papers), Antibiotic Use and Resistance (9 papers), Mycobacterium research and diagnosis (6 papers), Tuberculosis Research and Epidemiology (6 papers), Cytomegalovirus and herpesvirus research (6 papers), COVID-19 Clinical Research Studies (5 papers), Urinary Tract Infections Management (5 papers) and Appendicitis Diagnosis and Management (5 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (51 citations), Molecular Medicine (58 citations) and Infectious Diseases (205 citations). Vildan Avkan-Oğuz has collaborated with scholars based in Türkiye, United States and Kazakhstan. Frequent co-authors include Nur Yapar, Güven Aslan, Tarkan Ünek, Ayşe Yüce, Sema Alp Çavuş, Mücahit Özbilgin, Mert Akan, Sevda Özkardeşler, İbrahim Astarcıoğlu and Bülent Ertuğrul. Their work appears in journals such as SHILAP Revista de lepidopterología, Journal of Antimicrobial Chemotherapy and Vaccine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.